Nephrology Doctors in Texarkana, TX Accepting Medicare

7 Nephrology doctors found. Showing 1 - 7

Mr. Robert James Leach, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5002 Cowhorn Creek Rd, Texarkana, TX 75503 Phone: 903-614-3000    Fax: 903-614-3525

Jason Z Lee, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5002 Cowhorn Creek Rd, Texarkana, TX 75503 Phone: 903-614-3000    Fax: 903-614-3525

Hayden N Hemphill, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5002 Cowhorn Creek Rd, Texarkana, TX 75503 Phone: 903-614-3000    Fax: 903-614-3525

John O Stevens, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5002 Cowhorn Creek Rd, Texarkana, TX 75503 Phone: 903-614-3000    Fax: 903-614-3525

Bayard Paul Quinn, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5002 Cowhorn Creek Rd, Texarkana, TX 75503 Phone: 903-614-3000    Fax: 903-614-3525

Jarrell T Myrick, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5002 Cowhorn Creek Rd, Texarkana, TX 75503 Phone: 903-614-3000    Fax: 903-614-3525

Dr. Muazer Ahmed, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5002 Cowhorn Creek Rd, Texarkana, TX 75503 Phone: 903-614-3000    Fax: 903-614-3525

News Archive

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.

Brain's reaction to sadness can predict risk of future depression

Depression is increasingly recognized as an illness that strikes repeatedly over the lifespan, creating cycles of relapse and recovery. This sobering knowledge has prompted researchers to search for markers of relapse risk in people who have recovered from depression.

Oxford BioTherapeutics, Boehringer Ingelheim team up to discover novel cancer antibody targets

Oxford BioTherapeutics and Boehringer Ingelheim today announce a new alliance focused on the discovery of novel cancer antibody targets that OBT will identify with the help of its OGAP® discovery platform.

Study finds serious long-term side effects following prostate cancer treatments

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.

Read more Medical News

› Verified 1 days ago